Rheumatology Journals Rife With Faulty Conflict-of-Interest More often than not, conflict-of-interest disclosures in three major rheumatology journals didn't match records in the U.S. government's Open Payments database, researchers found. https://t.co/LKyEURZrQY https://t.co/EQLSWXB3o2

• https://bit.ly/43VY2EY

Mark your calendars! The highly anticipated Association of Women in Rheumatology 2023 conference is just a few weeks away! Don't miss this incredible opportunity to join in virtually for FREE! Register now and secure your spot https://t.co/qqq4c1p6De

• Association of Women in Rheumatology - Annual Conference 2023

Multi-media, sponsor-generated clinical trial posters presented at major rheumatology meetings are now available in RheumNow’s newest offering: the Poster Hall. https://t.co/4WRpwh8iRa https://t.co/ZGKDqfjb7Y

• https://bit.ly/43UZpUf

2023-2024 Best Rheumatology Hospitals Johns Hopkins Hospital in Baltimore has been named the top hospital for rheumatology by U.S. News & World Report. This is the 6th year in a row they have held this spot. https://t.co/gGsBr1s0RE https://t.co/Ku6tdzit84

• https://bit.ly/45aPCLr

Tofacitinib in Polymyalgia Rheumatica (EAST PMR Study) An open-label, uncontrolled pilot trial has shown that JAK signaling is involved in the pathogenesis of PMR and that tofacitinib is as effective as glucocorticoids (GC) in patients with PMR. https://t.co/XQL7bfkkho https://t.co/HJ2aSIG0rn

• https://bit.ly/3QqUasg

Spinal CT study of 40 ankylosing spondylitis pts shows the most common site and region of intervertebral fusion were the posterior vertebrae of the middle thoracic region >50% halffused posterior vertebrae Th4–Th5 to Th7–Th8, followed by Cx, last lumbar https://t.co/HzJmpROJmr https://t.co/9qUwlGyBQz

• https://bit.ly/45f1FXt

High mortality risk predictors in patients with anti-MDA5 dermatomyositis include: - rapidly progressive interstitial lung disease - anti-Ro52 antibody - age > 57 years (based on study of 126 MDA-5+ DM pts) https://t.co/JLGIgALUip https://t.co/boTTzrixk9

• https://bit.ly/3DGa6iW

Spanish study of 518 #SLE patients, 7% of whom received at least one dose of rituximab(26) or belimumab (11). RTX given for either hemolytic anemia or ITP (11 pts), nephritis & CNS SLE (5 pts ea). BEL mostlyfor arthritis (8 pts) https://t.co/cgC837Na81 https://t.co/bndKVqNsSE

• https://bit.ly/3Qv3hZ0

2023 ACR/EULAR Criteria for Calcium Pyrophosphate Deposition Disease The prevalence of radiographic chondrocalcinosis is estimated to be 4% to ≥10% in older adults, but the prevalence of symptomatic CPPD disease is unknown. https://t.co/F0aQR7ZDeU https://t.co/ugXkDmOVML

• https://bit.ly/45hTiuc

SGLT2 inhibitor (empagliflozin) given in a lupus mouse (MRL/lpr) model showed a renoprotective effect suggesting the value of non-immunosuppressive therapies to improve renal function. Showed less -dsDNA Abs, proteinuria, renal nephritis damage https://t.co/uJjr7rTIJe https://t.co/ptTvwWJlvO

• https://bit.ly/3DKMv0E

Multi-media, sponsor-generated clinical trial posters presented at major rheumatology meetings are now available in RheumNow’s newest offering: the Poster Hall. https://t.co/YQW2wN9X25 https://t.co/BS9jZRLUo4

• https://bit.ly/3rXzRsi

Composite Measures to Inform Treatment Choices in Bio-naïve Patients with PsA What is an option for treating and managing bio-naïve patients with PsA? Dr. Mease and Dr. Khattri discuss. Therapeutic update sponsored by AbbVie US Medical Affairs. https://t.co/xha5gyHqor https://t.co/mINKK0ybVD

• https://bit.ly/43TOkCT

2023-2024 Best Rheumatology Hospitals Johns Hopkins Hospital in Baltimore has been named the top hospital for rheumatology by U.S. News & World Report. This is the 6th year in a row they have held this spot. https://t.co/4k6DNJie4n https://t.co/BbPlEFAGH3

• https://bit.ly/3OHKRmB

Paradoxical Rxns (PR) & biologics in TReasure database: 2867 RA & 5316 SpA pts; 5-yr FUV found 136 pts (1.7%) developed the PRs; 60% w/ 1st biologic, after median 12 mos, 93% psoriais (pustular 60%, palmoplantar 31%), many better w/ another TNFi https://t.co/5tybXZZVKW https://t.co/1nQaXQOEDD

• https://bit.ly/3qfeN03

HEALTH DISPARITIES: Lancet study shows from 2000-2019, all-cause mortality was signif. higher in the American Indian/Alaska Native (1028/100K) & Blacks (953·/100K) compared to Whites (802); but lower in Asians (442) & Latinos (595) https://t.co/g8Z3h6BYw8 https://t.co/Ckz1L3O0W7

• https://bit.ly/45eZ67L